Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker-Driven Radiation Dose Reduction After TORS in Patients With HPV-Positive Oropharyngeal Cancer

NCT05387915 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT05387915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05387915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker-Driven Radiation Dose Reduction After TORS in Patients With HPV-Positive Oropharyngeal Cancer
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 6, 2022
Completion date
January 5, 2028
Enrollment
33 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

clinical stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, oropharyngeal hpv-positive squamous cell carcinoma